The estimated Net Worth of Michael D Dale is at least $6.25 Million dollars as of 28 February 2023. Mr. Dale owns over 1,209 units of Abbott Laboratories stock worth over $5,262,508 and over the last 5 years he sold ABT stock worth over $988,590. In addition, he makes $0 as Senior Vice President - Structural Heart at Abbott Laboratories.
Michael has made over 7 trades of the Abbott Laboratories stock since 2020, according to the Form 4 filled with the SEC. Most recently he sold 1,209 units of ABT stock worth $121,746 on 28 February 2023.
The largest trade he's ever made was exercising 17,600 units of Abbott Laboratories stock on 28 July 2021 worth over $892,672. On average, Michael trades about 2,210 units every 92 days since 2020. As of 28 February 2023 he still owns at least 45,133 units of Abbott Laboratories stock.
You can see the complete history of Mr. Dale stock trades at the bottom of the page.
Michael Donald Dale serves as Senior Vice President - Structural Heart of the Company. He serves as Vice President, Structural Heart from 2017 to 2019. Divisional Vice President and General Manager, Structural Heart from 2016-2017. President and Chief Executive Officer, GI Dynamics, Inc. (a medical device company focused on developing gastrointestinal therapies) from 2014-2016.
Michael Dale is 60, he's been the Senior Vice President - Structural Heart of Abbott Laboratories since 2019. There are 16 older and 26 younger executives at Abbott Laboratories. The oldest executive at Abbott Laboratories is Samuel Scott, 75, who is the Independent Director.
Michael's mailing address filed with the SEC is C/O AXOGEN, INC., 13631 PROGRESS BLVD., SUITE 400, ALACHUA, FL, 32615.
Over the last 24 years, insiders at Abbott Laboratories have traded over $388,257,551 worth of Abbott Laboratories stock and bought 1,028,477 units worth $44,923,618 . The most active insiders traders include Miles D White, Richard A Gonzalez und Jeffrey M Leiden. On average, Abbott Laboratories executives and independent directors trade stock every 9 days with the average trade being worth of $4,003,344. The most recent stock trade was executed by John A. Jr. Mccoy on 1 September 2024, trading 27 units of ABT stock currently worth $3,100.
Abbott Laboratories is an American multinational medical devices and health care company with headquarters in Abbott Park, Illinois, United States.
Abbott Laboratories executives and other stock owners filed with the SEC include: